EUVIMEDEUVIMED entdecken
Crossref

MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer’s Disease by modulating Hippo-Wnt signaling crosstalk

Manas Ranjan Sahu, Mir Hilal Ahmad, Amal Chandra Mondal

Apoptosis · 2024

DOI: 10.1007/s10495-024-01975-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Manas Ranjan Sahu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Apoptosis, Disease Models, Animal, Wnt Signaling Pathway. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 92 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD), the most prevalent form of dementia, is characterized by progressive cognitive impairment accompanied by aberrant neuronal apoptosis. Reports suggest that the pro-apoptotic mammalian set20-like kinase 1/2 (MST1/2) instigates neuronal apoptosis via activating the Hippo signaling pathway under various stress conditions, including AD. However, whether inhibiting MST1/2 has any therapeutic benefits in AD remains unknown. Thus, we tested the therapeutic effects of intervening MST1/2 activation via the pharmacological inhibitor Xmu-mp-1 in a sporadic AD rat model. Sporadic AD was established in adult rats by intracerebroventricular streptozotocin (ICV-STZ) injection (3 mg/kg body weight). Xmu-mp-1 (0.5 mg/kg/body weight) was administered once every 48 h for two weeks, and Donepezil (5 mg/kg body weight) was used as a reference standard drug. The therapeutic effects of Xmu-mp-1 on ICV-STZ rats were determined through various behavioral, biochemical, histopathological, and molecular tests. At the behavioral level, Xmu-mp-1 improved cognitive deficits in sporadic AD rats. Further, Xmu-mp-1 treatment reduced STZ-associated tau phosphorylation, amyloid-beta deposition, oxidative stress, neurotoxicity, neuroinflammation, synaptic dysfunction, neuronal apoptosis, and neurodegeneration. Mechanistically, Xmu-mp-1 exerted these neuroprotective actions by inactivating the Hippo signaling while potentiating the Wnt/β-Catenin signaling in the AD rats. Together, the results of the present study provide compelling support that Xmu-mp-1 negated the neuronal dysregulation in the rat model of sporadic AD. Therefore, inhibiting MST/Hippo signaling and modulating its crosstalk with the Wnt/β-Catenin pathway can be a promising alternative treatment strategy against AD pathology. This is the first study providing novel mechanistic insights into the therapeutic use of Xmu-mp-1 in sporadic AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseApoptosisDisease Models, AnimalWnt Signaling PathwayAnimalsMaleRatsHepatocyte Growth FactorHippo Signaling PathwayNeuronsProtein Serine-Threonine KinasesProto-Oncogene ProteinsRats, Sprague-DawleyStreptozocin

Stichwörter der Autor:innen

Alzheimer’s diseaseApoptosisHippo SignalingMST1StreptozotocinWnt/β-Catenin signalingXmu-mp-1

Substanzen

Hepatocyte Growth Factormacrophage stimulating proteinProtein Serine-Threonine KinasesProto-Oncogene ProteinsStreptozocin

Autor:innen und Institutionen

  • Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.
  • Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. acmondal@mail.jnu.ac.in.

Zitieren

APA

Sahu, M. R., Ahmad, M. H., & Mondal, A. C. (2024). MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer’s Disease by modulating Hippo-Wnt signaling crosstalk. Apoptosis. https://doi.org/10.1007/s10495-024-01975-0

Vancouver

Sahu MR, Ahmad MH, Mondal AC. MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer’s Disease by modulating Hippo-Wnt signaling crosstalk. Apoptosis. 2024. doi:10.1007/s10495-024-01975-0

BibTeX
@article{Sahu2024,
  author = {Sahu, Manas Ranjan and Ahmad, Mir Hilal and Mondal, Amal Chandra},
  title = {MST1 selective inhibitor Xmu-mp-1 ameliorates neuropathological changes in a rat model of sporadic Alzheimer’s Disease by modulating Hippo-Wnt signaling crosstalk},
  journal = {Apoptosis},
  year = {2024},
  doi = {10.1007/s10495-024-01975-0}
}
Kostenlos starten →